LakeShore Biopharma Co (LakeShore Biopharma Co) Dividends per Share : $0.00 (TTM As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Dividends per Share?

LakeShore Biopharma Co's dividends per share for the six months ended in Sep. 2023 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00. Its Dividend Payout Ratio for the six months ended in Sep. 2023 was 0.00. As of today, LakeShore Biopharma Co's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

LakeShore Biopharma Co Dividends per Share Historical Data

The historical data trend for LakeShore Biopharma Co's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Dividends per Share Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Dividends per Share

LakeShore Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Dividends per Share	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of LakeShore Biopharma Co's Dividends per Share

For the Biotechnology subindustry, LakeShore Biopharma Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LakeShore Biopharma Co's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Dividend Yield % falls into.

LakeShore Biopharma Co Dividends per Share Calculation

Dividends paid to per common share.

LakeShore Biopharma Co (NAS:LSB) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

LakeShore Biopharma Co's Dividend Payout Ratio for the quarter that ended in Sep. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2023 )	/	EPS without NRI (Q: Sep. 2023 )
	=	0	/	-0.268
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

LakeShore Biopharma Co Dividends per Share Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.